L Placidi

436 total citations
16 papers, 361 citations indexed

About

L Placidi is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, L Placidi has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in L Placidi's work include HIV/AIDS drug development and treatment (9 papers), Hepatitis B Virus Studies (6 papers) and Hepatitis C virus research (5 papers). L Placidi is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Hepatitis B Virus Studies (6 papers) and Hepatitis C virus research (5 papers). L Placidi collaborates with scholars based in United States, France and Puerto Rico. L Placidi's co-authors include Jean‐Pierre Sommadossi, Erika Cretton-Scott, M. Placidi, Gilles Gosselin, Jean‐Louis Imbach, Claire Pierra, Martin L. Bryant, David Dukhan, Edward G. Bridges and Raymond F. Schinazi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

L Placidi

15 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Placidi United States 9 184 157 136 123 60 16 361
Violetta Skalski Canada 8 116 0.6× 67 0.4× 169 1.2× 242 2.0× 97 1.6× 14 436
Jillian DiMuzio United States 11 96 0.5× 152 1.0× 108 0.8× 225 1.8× 27 0.5× 17 549
Kevin M. Cottrell United States 7 153 0.8× 211 1.3× 102 0.8× 173 1.4× 30 0.5× 21 413
Bipin C. Dash United States 10 62 0.3× 32 0.2× 87 0.6× 253 2.1× 127 2.1× 10 443
Jingjin Gao United States 8 92 0.5× 160 1.0× 111 0.8× 123 1.0× 69 1.1× 11 337
Songping Zhao Canada 9 75 0.4× 107 0.7× 77 0.6× 251 2.0× 55 0.9× 13 473
Mong-Liang Chen Taiwan 12 252 1.4× 174 1.1× 39 0.3× 269 2.2× 96 1.6× 14 572
Reem El‐Shenawy Egypt 12 178 1.0× 186 1.2× 23 0.2× 123 1.0× 28 0.5× 42 388
Karen Prus United States 9 112 0.6× 16 0.1× 202 1.5× 146 1.2× 52 0.9× 17 398
Sergio Serafini Italy 11 43 0.2× 69 0.4× 36 0.3× 292 2.4× 109 1.8× 11 393

Countries citing papers authored by L Placidi

Since Specialization
Citations

This map shows the geographic impact of L Placidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Placidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Placidi more than expected).

Fields of papers citing papers by L Placidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Placidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Placidi. The network helps show where L Placidi may publish in the future.

Co-authorship network of co-authors of L Placidi

This figure shows the co-authorship network connecting the top 25 collaborators of L Placidi. A scholar is included among the top collaborators of L Placidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Placidi. L Placidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hernández-Santiago, Brenda I., L Placidi, Achraf Al Faraj, et al.. (2002). Pharmacology of β- l -Thymidine and β- l -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 46(6). 1728–1733. 43 indexed citations
2.
3.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations
4.
Placidi, L, Achraf Al Faraj, Claire Pierra, et al.. (2001). Antiviral Activity and Intracellular Metabolism of Bis(tButylSATE) Phosphotriester of β-L-2′,3'Dideoxyadenosine, a Potent Inhibitor of HIV and HBV Replication. Antiviral chemistry & chemotherapy. 12(2). 99–108. 9 indexed citations
5.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). Antiviral l -Nucleosides Specific for Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 45(1). 229–235. 144 indexed citations
6.
Bidanset, Deborah J., et al.. (2001). Intravenous Infusion of Cereport Increases Uptake and Efficacy of Acyclovir in Herpes Simplex Virus-Infected Rat Brains. Antimicrobial Agents and Chemotherapy. 45(8). 2316–2323. 6 indexed citations
7.
Cretton-Scott, Erika, L Placidi, Abdesslem Faraj, et al.. (2000). In Vitro and In Vivo Metabolism and Pharmacokinetics ofbis[(T-Butyl)-S-acyl-2-thioethyl]-β-L-2′,3′-dideoxy-5-fluorocytidine Monophosphate. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 481–499. 6 indexed citations
8.
Placidi, L, Erika Cretton-Scott, Gilles Gosselin, et al.. (2000). Intracellular Metabolism of β- l -2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity. Antimicrobial Agents and Chemotherapy. 44(4). 853–858. 8 indexed citations
9.
Faraj, Achraf Al, L Placidi, Christian Périgaud, et al.. (1999). Intracellular Metabolism of β-L-ddAMP-bis(tbutylSATE), a Potent Inhibitor of Hepatitis B Virus Replication. Nucleosides and Nucleotides. 18(4-5). 987–988. 2 indexed citations
10.
Placidi, L, et al.. (1999). Metabolic Drug Interactions between Angiogenic Inhibitor, Tnp-470 and Anticancer Agents in Primary Cultured Hepatocytes and Microsomes. Drug Metabolism and Disposition. 27(5). 623–626. 8 indexed citations
11.
Placidi, L, et al.. (1998). [Recent acquisitions in epidemiology and prevention of virus A hepatitis. Hepatitis-infection and icteric hepatitis].. PubMed. 146. 486–94.
12.
Placidi, L, et al.. (1997). Interspecies variability of TNP-470 metabolism, using primary monkey, rat, and dog cultured hepatocytes.. PubMed. 25(1). 94–9. 11 indexed citations
13.
Cretton-Scott, Erika, L Placidi, Harold M. McClure, Daniel C. Anderson, & Jean‐Pierre Sommadossi. (1996). Pharmacokinetics and metabolism of O -(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys. Cancer Chemotherapy and Pharmacology. 38(2). 117–122. 26 indexed citations
14.
Placidi, L, et al.. (1995). Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes.. PubMed. 55(14). 3036–42. 36 indexed citations
15.
Placidi, L, E M Cretton, M. Placidi, & Jean‐Pierre Sommadossi. (1993). Reduction of 3′-azido-3′-deoxythymidine to 3′-amino-3′-deoxythymidine in human liver microsomes and its relationship to cytochrome P450. Clinical Pharmacology & Therapeutics. 54(2). 168–176. 31 indexed citations
16.
Placidi, L, et al.. (1957). [Virus disease of sheep from new introduction in Europe and North Africa: blue tongue; epidemiological note].. PubMed. 36(381). 142–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026